David Jones
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
Papers in
- Pharmacology 17
- Pharmacogenetics and Drug Metabolism 15
-
- Cancer Genomics and Diagnostics 9
- Co-authors
- Stephen D. HallJamie L. RenbargerJennifer B. DennisonIsabel MéridaSteven WrightonRobert H. FitzgeraldNkechi AzieD. Craig Brater
- Journals
- Drug Metabolism and Disposition (4 papers)Journal of Clinical Oncology (4 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Clinical Cancer Research (2 papers)Current Protocols in Bioinformatics (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
David Jones
57 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 128
- Pharmacology 679
- Oncology 819
- Cancer Research 344
- Hematology 151
- Pharmacology 196
Countries citing papers authored by David Jones
This map shows the geographic impact of David Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jones more than expected).
Fields of papers citing papers by David Jones
This network shows the impact of papers produced by David Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jones. The network helps show where David Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside David Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 20 | |
| 2 | CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer | 2018 | 5 |
| 3 | 2017 | 13 | |
| 4 | 2016 | 28 | |
| 5 | 2016 | 28 | |
| 6 | 2016 | 28 | |
| 7 | 2016 | 25 | |
| 8 | 2014 | 3 | |
| 9 | 2014 | 14 | |
| 10 | 2013 | 18 | |
| 11 | 2011 | 75 | |
| 12 | 2009 | 6 | |
| 13 | 2007 | 113 | |
| 14 | 2006 | 54 | |
| 15 | 2004 | 31 | |
| 16 | 2004 | 151 | |
| 17 | 2004 | 10 | |
| 18 | 2000 | 60 | |
| 19 | 1999 | 122 | |
| 20 | 1998 | 11 |
About David Jones
David Jones is a scholar working on Pharmacology, Cancer Research, Oncology, Filtration and Separation and Pharmacology, having authored 58 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Cancer Treatment and Pharmacology (12 papers), Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Analytical Chemistry and Chromatography (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Pharmacology (679 citations), Oncology (819 citations), Cancer Research (344 citations), Hematology (151 citations) and Pharmacology (196 citations). David Jones has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Stephen D. Hall, Jamie L. Renbarger, Jennifer B. Dennison, Isabel Mérida, Steven Wrighton, Robert H. Fitzgerald, Nkechi Azie, D. Craig Brater, Serena Nik‐Zainal and Paul S. Jones. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics, Clinical Cancer Research and Current Protocols in Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.